Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Cerny

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2016
Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015Matthew A Cerny
Current Topics in Medicinal Chemistry|May 22, 2013
Progress towards clinically useful aldosterone synthase inhibitorsMatthew A Cerny
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 14, 2026
Prevalence of non-cytochrome P450-mediated metabolism in food and drug administration-approved drugs: 2005-2024Matthew A Cerny
Methods in Enzymology|October 20, 2023
High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivationDrake A Russell, Matthew A Cerny
Archives of Biochemistry and Biophysics|March 31, 2005
Cyclopropylamine inactivation of cytochromes P450: role of metabolic intermediate complexesMatthew A Cerny, Robert P Hanzlik
Journal of the American Chemical Society|March 9, 2006
Cytochrome P450-catalyzed oxidation of N-benzyl-N-cyclopropylamine generates both cyclopropanone hydrate and 3-hydroxypropionaldehyde via hydrogen abstraction, not single electron transferMatthew A Cerny, Robert P Hanzlik
The Journal of Steroid Biochemistry and Molecular Biology|August 26, 2015
Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for humanMatthew A Cerny, Alexander Csengery, Jennifer Schmenk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2023
Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and ImportanceMatthew A Cerny, Douglas K Spracklin, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 3, 2018
Identification and Characterization of a Selective Human Carbonyl Reductase 1 SubstrateDiane Ramsden, Dustin Smith, Raquel Arenas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 3, 2021
Cytochrome P450 3A Time-Dependent Inhibition Assays Are Too Sensitive for Identification of Drugs Causing Clinically Significant Drug-Drug Interactions: A Comparison of Human Liver Microsomes and Hepatocytes and Definition of Boundaries for Inactivation Rate ConstantsHeather Eng, Elaine Tseng, Matthew A Cerny, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2016
Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015Matthew A Cerny
Current Topics in Medicinal Chemistry|May 22, 2013
Progress towards clinically useful aldosterone synthase inhibitorsMatthew A Cerny
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 14, 2026
Prevalence of non-cytochrome P450-mediated metabolism in food and drug administration-approved drugs: 2005-2024Matthew A Cerny
Methods in Enzymology|October 20, 2023
High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivationDrake A Russell, Matthew A Cerny
Archives of Biochemistry and Biophysics|March 31, 2005
Cyclopropylamine inactivation of cytochromes P450: role of metabolic intermediate complexesMatthew A Cerny, Robert P Hanzlik
Journal of the American Chemical Society|March 9, 2006
Cytochrome P450-catalyzed oxidation of N-benzyl-N-cyclopropylamine generates both cyclopropanone hydrate and 3-hydroxypropionaldehyde via hydrogen abstraction, not single electron transferMatthew A Cerny, Robert P Hanzlik
The Journal of Steroid Biochemistry and Molecular Biology|August 26, 2015
Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for humanMatthew A Cerny, Alexander Csengery, Jennifer Schmenk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2023
Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and ImportanceMatthew A Cerny, Douglas K Spracklin, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 3, 2018
Identification and Characterization of a Selective Human Carbonyl Reductase 1 SubstrateDiane Ramsden, Dustin Smith, Raquel Arenas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 3, 2021
Cytochrome P450 3A Time-Dependent Inhibition Assays Are Too Sensitive for Identification of Drugs Causing Clinically Significant Drug-Drug Interactions: A Comparison of Human Liver Microsomes and Hepatocytes and Definition of Boundaries for Inactivation Rate ConstantsHeather Eng, Elaine Tseng, Matthew A Cerny, et al.
Pageof 4